Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage

Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage

Background Severe or massive postpartum hemorrhage (PPH) has remained a leading cause of maternal mortality for decades across the world and it results in critical obstetric complications. Recombinant activated factor VII (rFVIIa) has emerged as a gold standard adjunctive hemostatic agent for the tr...

Full description

Bibliographic Details
Main Authors: Soon Chang Park, Seok Ran Yeom, Sang Kyoon Han, Young Mo Jo, Hyung Bin Kim
Format: Article
Language:English
Published: Korean Society of Critical Care Medicine 2017-11-01
Series:Korean Journal of Critical Care Medicine
Subjects:
factor VIIa
maternal death
organ dysfunction scores
postpartum hemorrhage
recombinant proteins
Online Access:http://www.kjccm.org/upload/pdf/kjccm-2016-00787.pdf

Internet

http://www.kjccm.org/upload/pdf/kjccm-2016-00787.pdf

Similar Items